GLAXOSMITHKLINE PLC-SPON ADR

GSK stock holders 13F

4 superinvestors reported owning GSK (ADR) according to the gurus' 2022 Q2 reports.

Top 4 gurus who own (GSK) GLAXOSMITHKLINE PLC-SPON ADR

The 4 super investors (holders) owning GSK (by the percentage (%) of portfolio) are Thomas Graham, Alan, Irving Kahns - Kahn Brothers Group (8.39%), Mark A. Hillman - Hillman Value Fund (3.34%), V. D. Dodge, E. M. Cox - Dodge & Cox Stock Fund (2.67%) and B. Tweedy, Ch. Browne - Tweedy, Browne Co All Funds (US) (0.34%) as of their 2022 Q2 reports.

To check the latest activities of the top GSK shareholders between value investors, please click on the "Activity" tab.

To see the historical data of GSK's holders please click on the "2022 Q2" dropdown menu and select the date.

# of holders: 4

Period: 2022 Q2

Type: ADR

History

% change to
Portfolio

B. Tweedy, Ch. Browne

Tweedy, Browne Co All Funds (US)

0.34%

107,397

$54.41

$5,843,745

-3.25% (-3,608)

-0.01%

Mark A. Hillman

Hillman Value Fund

3.34%

128,000

$54.41

$6,964,800

Thomas Graham, Alan, Irving Kahns

Kahn Brothers Group

8.39%

990,362

$54.41

$53,887,745

+0.32% (+3,111)

+0.03%

V. D. Dodge, E. M. Cox

Dodge & Cox Stock Fund

2.67%

20,961,478

$54.41

$1,140,566,431

-13.26% (-3,203,860)

-0.41%

Current price: $33.96 37.59% AVG reported hold price*: $54.41

Completely sold out

History

Name

Company

Sold
Shares*

% change to
Portfolio

Sarah Ketterer

Causeway Capital Management

177,763

-0.28%

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.